Press Release Archive
Press Releases
June 2020
06.11.2020 Medicines FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf) 06.10.2020 Research Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis 06.03.2020 Research Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology 06.02.2020 Finance Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 06.02.2020 Pfizer Establishes New Program to Support Continued Biotechnology Innovation
May 2020
05.29.2020 Medicines Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer 05.29.2020 Medicines Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer 05.28.2020 Partnerships Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging 05.28.2020 Partnerships Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging 05.22.2020 Finance Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC 05.18.2020 Finance Pfizer Prices $4,000,000,000 Debt Offering 05.15.2020 Research Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.